Search

everythinglearnresearchcommunity

for

Search:↓

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Ovarian stromal volume doesn't relate to PCOS biochemical indices.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Training improves consistency in evaluating polycystic ovaries with ultrasound.

Women of reproductive age with polycystic ovary syndrome often experience hair loss.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Exercising women with irregular periods have lower thyroid hormone levels and less body fat.

Women with PCOS have different hormone levels compared to those without PCOS.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Polycystic ovaries are defined by having 12 or more small follicles in each ovary and are found in up to 33% of women, while Polycystic Ovary Syndrome (PCOS) is the most common hormone disorder in women of reproductive age, potentially increasing risk of obesity, diabetes, and heart diseases.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Laparoscopic ovarian drilling improves menstrual cycles, hormone levels, and pregnancy rates in women with PCOS.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Medroxyprogesterone acetate is as effective as oral contraceptives for resuming ovulation in women with PCOS.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

Ultrasound alone isn't enough to diagnose PCOS.

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

PCOS may be influenced by factors in the blood, not just the ovaries.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS often have different clinical signs, hormone levels, and gynecological issues compared to those without the condition.

Skin problems like acne and excessive hair growth are common in people with Polycystic Ovarian Syndrome, especially those with 15-16 follicles in their ovaries.